✦ LIBER ✦

Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer

✍ Scribed by D.M. Sopka; Y.S. Chun; S.J. Cohen; F. Zhu; B.N. Milestone; H.S. Cooper; G.M. Freedman; B.A. Burtness; J.P. Hoffman; J.E. Meyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant Chemoradiation With Intensit

✍ Kharofa, J.R.; Kelly, T.; Wood, C.; George, B.; Tsai, S.; Ritch, P.; Wiebe, L.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Neoadjuvant chemoradiotherapy with S-1 i

✍ Shimizu, Dai; Fujii, Tsutomu; Hattori, Masashi; Suenaga, Masaya; Yamada, Suguru; 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 50 KB

Gemcitabine based neoadjuvant chemoradio

✍ Cho, In Rae; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 362 KB

Management of Borderline Resectable Panc

✍ Horowitz, D.P.; Ebiana, V.; Gidea-Addeo, D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Potential Contribution of Preoperative N

✍ Chang Moo Kang; Yong Eun Chung; Jeong Youp Park; Jin Sil Sung; Ho Kyoung Hwang; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Neoadjuvant chemotherapy with gemcitabin

✍ Matsushita, Akira; Nakamura, Yoshiharu; Sumiyoshi, Hiroki; Aimoto, Takayuki; Yok 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 42 KB